Erratum: Changes in bone resorption across the menopause transition: Effects of reproductive hormones, body size, and ethnicity (Journal of Clinical Endocrinology and Metabolism (2013) 98 (2854-2863) DOI: 10.1210/jc.2012-4113);Changes in bone resorption across the menopause transition: Effects of reproductive hormones, body size, and ethnicity

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 7, 2013, Pages 2854-2863

  Sowers, MaryFran R ^a   Zheng, Huiyong ^a   Greendale, Gail A ^b   Neer, Robert M ^c   Cauley, Jane A ^d   Ellis, Jayne ^e   Johnson, Sarah ^f   Finkelstein, Joel S ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e Alere International   (United Kingdom)

^f SPD Development Company Limited   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; ESTRADIOL; FOLLITROPIN;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; BODY SIZE; CAUCASIAN; CHINESE; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; FINAL MENSTRUAL PERIOD; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; JAPANESE; MENOPAUSE; MENSTRUAL CYCLE; OSTEOLYSIS; OVARY FUNCTION; PRIORITY JOURNAL; PROTEIN URINE LEVEL;

EID: 84879989534     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2038     Document Type: Erratum

References (52)

1. Greendale GA, Sowers M, Han W, et al. Bone mineral density loss in relation to the final menstrual period in a multietnhic cohort: results from the Study of Women's Health Across the Nation (SWAN). J Bone Miner Res. 2012;27:111-118.
2. Ebeling PR, Atley LM, Guthrie JR, Bet al. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab. 1996;81:3366-3371. (Pubitemid 26296217)
3. Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab. 1994;79:1693-1700.
4. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res. 1996;11:337-349. (Pubitemid 26076383)
5. Gorai I, Taguchi Y, Chaki O, Nakayama M, Minaguchi H. Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: correlation with other markers of bone turnover. Calcif Tissue Int. 1997;60:317-322. (Pubitemid 27143442)
6. Hanson DA, Weis MA, Bollen AM, Maslan SL, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res. 1992;7:1251-1258. (Pubitemid 23000964)
7. de Papp AE, Bone HG, Caulfield MP, et al. A cross-sectional study of bone turnover markers in healthy premenopausal women. Bone. 2007;40:1222-1230. (Pubitemid 46550988)
8. Sowers MR, Zheng H, McConnell D, Nan B, Harlow S, Randolph JF Jr. Follicle stimulating hormone and its rate of change in defining menopause transition stages. J Clin Endocrinol Metab. 2008;93:3958-3964.
9. Sowers MR, Zheng H, McConnell D, Nan B, Harlow SD, Randolph JF Jr. Estradiol rates of change in relation to the final menstrual period in a population-based cohort of women. J Clin Endocrinol Metab. 2008;93:3847-3852.
10. Finkelstein JS, Brockwell SE, Mehta V, et al. Bone mineral density çhanges during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab. 2008;93:861-868. (Pubitemid 351398564)
11. Ravn P, Cizza G, Bjarnason NH, et al. Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group. J Bone Miner Res. 1999;14:1622-1627. (Pubitemid 29416690)
12. Macdonald HM, New SA, Campbell MK, Reid DM. Influence of weight and weight change on bone loss in perimenopausal and early postmenopausal Scottish women. Osteoporos Int. 2005;6:163-171. (Pubitemid 40193203)
13. Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas. 1995;21:103-113.
14. Sowers MR, Finkelstein JS, Ettinger B, et al. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN. Osteoporos Int. 2003;14:44-52. (Pubitemid 36267900)
15. Sowers MF, Crawford S, Sternfeld B, et al. Design, survey, sampling and recruitment methods of SWAN: a multi-center, multi-ethnic, community based cohort study of women and the menopausal transition. In: Lobo RA, Kelsey J, Marcus M, eds. Menopause: Biology and Pathobiology. San Diego, CA: Academic Press; 2003:175-188.
16. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36:936-942. (Pubitemid 13214364)
17. Sternfeld B, Ainsworth BE, Quesenberry CP. Physical activity patterns in a diverse population of women. Prev Med. 1999;28:313-323. (Pubitemid 29372465)
18. Zhang D, Lin X, Sowers M. Semiparametric stochastic mixed models for longitudinal hormone data. J Am Stat Assoc. 1998;93:710-719.
19. Zheng H, Sowers MR, Randolph JF Jr, Hawlow SD. An integrated quantitative methodology to longitudinally characterize complex dynamic processes associated with ovarian aging and the menopausal transition. J System Cybernet Informat. 2011;9:15-23.
20. Claeskens G, Van Keilegom I. Bootstrap confidence bands for regression curves and their derivatives. Ann Stat. 2003;31:1852-1884. (Pubitemid 38285093)
21. Efron B, Tibshirani R. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci. 1986;1:54-77.
22. Hoeting JA, Madigan D, Raftery AE, Vollinsky CT. Model averaging: A tutorial. Stat Sci. 1999;14:382-401.
23. Raftery AE. Bayesian model selection in social research. Sociol Methodol. 1995;25.
24. Neter J, Wasserman W, Kutner M. Applied Linear Statistical Models. 2nd ed. Homewood, IL: Irwin; 1985.
25. Finkelstein JS, Lee ML, Sowers M, et al. Ethnic variation in bone density in premenopausal and early perimenopausal women: effects of anthropometric and lifestyle factors. J Clin Endocrinol Metab. 2002;87:3057-3067. (Pubitemid 34816345)
26. Ahlborg HG, Johnell O, Nilsson BE, Jeppsson S, Rannevik G, Karlsson MK. Bone loss in relation to menopause: a prospective study during 16 years. Bone. 2001;28:327-331. (Pubitemid 32194419)
27. Riggs BL, Wahner HW, Melton LJ 3rd, Richelson LS, Judd HL, Offord KP. Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest. 1986;77:1487-1491. (Pubitemid 16047092)
28. Recker R, Lappe J, Davies K, Heaney R. Characterization of perimenopausal bone loss: a prospective study. J Bone Miner Res. 2000; 15:1965-1973.
29. Sowers MR, Zheng H, Jannausch ML, et al. Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause. J Clin Endocrinol Metab. 2010;95:2155-2162.
30. Cauley JA, Danielson ME, Greendale GA, et al. Bone resorption and fracture across the menopausal transition: the Study of Women's Health Across the Nation. Menopause. 2012;19:1200-1207.
31. Gourlay ML, Fine JP, Preisser JS, et al. Bone-density testing interval and transition to osteoporosis in older women. NEngl J Med. 2012; 366:225-233.
32. Yu EW, Finkelstein JS. Bone density screening intervals for osteoporosis: one size does not fit all. JAMA. 2012;307:2591-2592.
33. Black DM, Kelly MP, Genant HK, et al. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. 2010;362:1761-1771.
34. Kim SY, Schneeweiss S, Katz JN, Levin R, Solomon DH. Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort. J Bone Miner Res. 2011;26:993-1001.
35. Shane E, Burr D, Ebeling PR, et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010;25:2267-2294.
36. Woo SB, Hellstein JW, Kalmar JR. Narrative review: bisphosphonates and osteonecrosis of the jaws [published correction appears in Ann Intern Med. 2006;145:235]. Ann Intern Med. 2006;144:753-761. (Pubitemid 46780635)
37. Ahlborg HG, Johnell O, Turner CH, Rannevik G, Karlsson MK. Bone loss and bone size after menopause. N Engl J Med. 2003;349:327-334. (Pubitemid 36886238)
38. Cummings SR, Browner WS, Bauer D, et al. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1998;339:733-738. (Pubitemid 28417356)
39. Ettinger B, Pressman A, Sklarin P, Bauer DC, Cauley JA, Cummings SR. Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the study of osteoporotic fractures. J Clin Endocrinol Metab. 1998;83:2239-2243. (Pubitemid 28503008)
40. Guthrie JR, Ebeling PR, Hopper JL, et al. A prospective study of bone loss in menopausal Australian-born women. Osteoporos Int. 1998;8:282-290. (Pubitemid 28427079)
41. Chapurlat RD, Bauer DC, Cummings SR. Association between endogenous hormones and sex hormone-binding globulin and bone turnover in older women: study of osteoporotic fractures. Bone. 2001;29:381-387. (Pubitemid 32930066)
42. Chapurlat RD, Garnero P, Bréart G, Meunier PJ, Delmas PD. Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: the EPIDOS study. J Bone Miner Res. 2000;15:1835-1841. (Pubitemid 30666237)
43. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res. 2000;15:1526-1536. (Pubitemid 30484522)
44. Rogers A, Saleh G, Hannon RA, Greenfield D, Eastell R. Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women. J Clin Endocrinol Metab. 2002;87:4470-4475. (Pubitemid 35247027)
45. Hassager C, Colwell A, Assiri AM, Eastell R, Russell RG, Christiansen C. Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study. Clin Endocrinol (Oxf). 1992;37:45-50.
46. Kelly PJ, Pocock NA, Sambrook PN, Eisman JA. Age and menopause-related changes in indices of bone turnover. J Clin Endocrinol Metab. 1989;69:1160-1165. (Pubitemid 20010042)
47. Kushida K, Takahashi M, Kawana K, Inoue T. Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients. J Clin Endocrinol Metab. 1995;80:2447-2450.
48. Sun L, Peng Y, Sharrow AC, et al. FSH directly regulates bone mass. Cell. 2006;125:247-260.
49. Bolotin HH. Inaccuracies inherent in dual-energy x-ray absorptiometry in vivo bone mineral densitometry may flaw osteopenic/osteoporotic interpretations and mislead assessment of antiresorptive therapy effectiveness. Bone. 2001;28:548-555.
50. Bolotin HH, Sievänen H, Grashuis JL. Patient-specific DXA bone mineral density inaccuracies: quantitative effects of nonuniform extraosseous fat distributions. J Bone Miner Res. 2003;18:1020-1027. (Pubitemid 37294938)
51. Bolotin HH, Sievänen H, Grashuis JL, Kuiper JW, Järvinen TL. Inaccuracies inherent in patient-specific dual-energy X-ray absorptiometry bone mineral density measurements: comprehensive phantom-based evaluation. J Bone Miner Res. 2001;16:417-426. (Pubitemid 32105422)
52. Finkelstein JS, Sowers M, Greendale GA, Lee ML, Neer RM, Cauley JA, Ettinger B. Ethnic variation in bone turnover in pre- and early perimenopausal women: effects of anthropometric and lifestyle factors. J Clin Endocrinol Metab. 2002;87:3051-3056. (Pubitemid 34816344) Health Institutes of Health Institutes of Health Institutes of Health Institutes of Health Institutes of Health Institutes of Health Institutes of Health Institutes of Health Institutes of Health